606P Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results

Autor:	O. Fernandez Calvo, R. Villatoro, V. Castillo-Morales, David Olmos, N. Sanchez-Soler, N. Romero Laorden, David Lorente, P. Borrega, Javier Puente, Raquel Luque, Enrique A. Castro, S. Ros Martínez, F. Lopez Campos, Anselmo Enrique Ferrer Hernández, G. De Velasco, A. Fernandez-Freire, R. Lozano Mejorada, Enrique Gonzalez-Billalabeitia, Nuria Lainez, Urbano Anido
Rok vydání:	2021
Předmět:	Radium-223 Oncology medicine.medical_specialty business.industry Hematology medicine.disease Bone remodeling Prostate cancer Castration Resistance Serum biomarkers Internal medicine medicine business medicine.drug
Zdroj:	Annals of Oncology. 32:S648
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1119
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a1ca86e8968e5d1edc802937caf87af5 https://doi.org/10.1016/j.annonc.2021.08.1119 Zobrazit plný text záznamu